COMPOUND | CATEGORY | CAT. No. | CAS. No. | ACTIONS |
---|---|---|---|---|
(2-((diaminomethylene) amino)thiazol-5 yl)methyl carbamimido... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-43186 | 772304-31-1 | |
(Z)-3-(((2-((diaminomethylene)amino)thiazol-5-yl)methyl)thio... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-43189 | Not Available | |
1-(4-(chloromethyl)-4-hydroxy-4,5-dihydrothiazol-2-yl)guanid... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-ED-02047 | 95907-34-9 | |
2-(5-(chloromethyl)thiazol-2-yl)guanidine R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-44898 | 1378820-83-7 | |
Dediaminosulfonyl Hydroxymethyl Famotidine R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-T-14687 | 76823-94-4 | |
|
Impurity | CS-T-23422 | 76824-14-1 | |
|
Impurity | CS-O-36121 | 2169078-41-3 | |
|
Impurity | CS-ED-00772 | 124646-10-2 | |
|
Impurity | CS-T-23415 | 76833-47-1 | |
|
Impurity | CS-T-23416 | 89268-62-2 | |
Famotidine EP Impurity B (Dimaleate salt) R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-EO-03550 | 109467-08-5 | |
Famotidine EP Impurity B (Mandeleate salt) R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-EO-03549 | 89268-62-2 (Freebase) | |
|
Impurity | CS-T-16887 | 76824-17-4 | |
|
Impurity | CS-T-23419 | 107880-74-0 | |
|
Impurity | CS-T-15632 | 76823-97-7 | |
|
Impurity | CS-EO-03548 | 1020719-36-1 (Freebase) | |
Famotidine EP Impurity I Hydrochloride R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-P-06992 | 1020719-36-1 (free base) | |
|
Impurity | CS-O-52430 | ---- | |
|
Impurity | CS-O-44896 | 1644079-28-6 | |
|
Impurity | CS-O-57233 | ---- | |
|
Impurity | CS-O-49735 | 106433-44-7 | |
|
Impurity | CS-T-93830 | 106649-96-1 | |
|
Impurity | CS-O-59968 | ---- | |
|
Impurity | CS-O-46832 | 95853-46-6 | |
|
Impurity | CS-CK-00006 | 106649-95-0 |